Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study-Reference-Cited by-同舟云学术

Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study

Published:2020-02 Issue:2 Volume:19 Page:135-144
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Olanow C Warren,Factor Stewart A,Espay Alberto J,Hauser Robert A,Shill Holly A,Isaacson Stuart,Pahwa Rajesh,Leinonen Mika,Bhargava Parul,Sciarappa Ken,Navia Bradford,Blum David,xx xx

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference28 articles.

1. Prevalence of Parkinson's disease across North America;Marras;NPJ Parkinsons Dis,2018

2. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature;Ahlskog;Mov Disord,2001

3. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years;Hely;Mov Disord,2005

4. Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinson's disease;Olanow;Mov Disord,2013

5. Patient perception of dyskinesia in Parkinson's disease;Hung;J Neurol Neurosurg Psychiatry,2010

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dopamine agonists in the treatment of Parkinson's disease: the show must go on;Journal of Neural Transmission;2024-09-11

2. Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology;Journal of Neurology;2024-08-29

3. TGF-β1 mediates hypoxia-preconditioned olfactory mucosa mesenchymal stem cells improved neural functional recovery in Parkinson’s disease models and patients;Military Medical Research;2024-07-22

4. Sublingual apomorphine in the treatment of Parkinson’s disease;Journal of Neural Transmission;2024-05-14

5. Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients;Clinical and Translational Science;2024-05